Clinical Trial

Development and Validation of a Risk Prediction Model for Gastric Retention in Patients Undergoing Sedated Gastroscopy

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 11, 2026 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
Gastric retention not only compromises the quality of endoscopic examination but also significantly increases the risk of reflux and aspiration in sedated patients. Aspiration of gastric contents represents a critical anesthesia-related complication during the perioperative period, carrying substantial implications for anesthetic management. With the growing volume of sedated gastroscopy procedures, predicting gastric retention has become an urgent clinical priority. This prospective study aims to establish a standardized gastric residual volume (GRV) grading system to evaluate both the volume of retained gastric contents and its contributing factors in patients undergoing upper gastrointestinal endoscopy. We will systematically assess the impact of demographic characteristics, comorbidities, and medication history on gastric emptying function. This study will facilitate establishment of an endoscopy-based simplified assessment system for gastric retention.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-03.
Status change: Not Yet Recruiting → Recruiting 2026-03-09
Trial Details
NCT Number NCT07104214
Lead Sponsor Zhejiang University
Conditions Gastric Cancer Stage, Esophageal Cancer, Gastroparesis
Enrollment 5,000 participants
Start Date 2025-08-03
Primary Completion 2026-05-31 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-11